{
    "nctId": "NCT04973930",
    "briefTitle": "Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer",
    "officialTitle": "Pilot Randomized Feasibility Trial of Tele-Interpersonal Psychotherapy and Tele-Pharmacotherapy for Depression in Patients With Non-Metastatic Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Major Depressive Disorder, Breast Cancer, Venlafaxine",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Hamilton Depression Rating Scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of diagnosis of Stage I-III breast cancer (\\<10 years from diagnosis)\n* episode of major depressive disorder without psychotic features on Structured Clinical Interview for DSM-5 (SCID-5)\n* 24-item Hamilton Depression Rating Scale score \u226518\n* written informed consent\n\nExclusion Criteria:\n\n* Psychosis (by SCID-5 interview)\n* current moderate/severe substance use disorder (mild substance disorder is not an exclusion)\n* acute suicidal risk\n* history of non-response to (\\>6 week) trials of venlafaxine (\u2265225 mg/d) and escitalopram (\u226520 mg/d);\n* history of non-response to IPT (\\>4 sessions\n* receiving current medication or psychotherapy treatment for depression\n* acute medical instability (too physically debilitated to participate in trial) or delirium\n* inability to complete self-administered questionnaires in English\n* current enrollment in a therapeutic oncology trial\n* known metastases",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}